Regen BioPharma, Inc., a subsidiary of Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN), is a biotechnology company focused on identifying undervalued regenerative medicine applications in the stem cell space and rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials.
Regen BioPharma identifies 30 promising technologies for rapid commercialization
Narrowed from a review of more than 20,000 US issued patents covering stem cell related matter, Regen BioPharma us in negotiations to license several patents for cell therapy products...
Regen BioPharma, Inc., is a wholly owned
subsidiary of Bio-Matrix Scientific Group, Inc.
(OTCQB: BMSN) (PINKSHEETS: BMSN). Click
below to access SEC regulatory filings.
Bio-Matrix Scientific Group Recruits RNA Interference Pioneer Dr. David Suhy
SAN DIEGO, CA, Sep 17, 2013 (Marketwired via COMTEX) -- Bio-Matrix Scientific Group Inc. (OTCQB: BMSN) announced that it has recruited, Dr. David Suhy